Platelets-Rich Plasma (PRP) Market - Forecast(2019 - 2024)

Report Code: HCR 1229 Report Format: PDF + Excel (Delivery in 48 Hrs)

Platelets-Rich Plasma Market Overview:

According to the American Society of Plastic Surgeons, around 17.5 million cosmetic surgeries were performed in the U.S. in 2017.[1] Wound care treatment and management is the foremost post-surgical requirement in every medical sector. Advancements in bioengineering have led to the development of platelet-rich plasma (PRP), which is slowly gaining traction as a crucial component in modern surgical wound-healing, hemostasis, and blood coagulation processes.. Otherwise known as autologous conditioned plasma, PRP is a derivative formed through centrifugation of whole blood, a process which removes red blood cells. Preparation of PRP can be categorized on the basis of leukocyte and fibrin content which generally includes leukocyte-rich PRP (L-PRP), leukocyte reduced PRP (P-PRP), leukocyte reduced (pure PRP), leukocyte platelet-rich fibrin, and pure platelet-rich fibrin. PRP therapies find wide application in neurosurgery, orthopedic surgery, oral and maxillofacial surgery, and dental implants, owing to their ability to promote bone and tissue reconstruction and assist in the healing of wounds. All these factors have significantly propelled the global PRP market, causing it to cross a valuation of $220m in 2018. During the forecast period 2019 to 2025, the PRP therapy market, especially in the orthopedic segment is estimated to grow at a CAGR of 25%.

Platelets-Rich Plasma Market Outlook:

Increasing number of surgeries, chronic wounds, and orthopedic injuries is boosting the global PRP market which is expected to increase at a CAGR of 12.32% through to 2025. According to the American Academy of Derma, hair loss affects nearly 10 million people in the U.S.[2] PRP therapy for hair loss, which involves injecting the plasma into hair follicles in a bid to induce blood flow and hair thickness and regrowth, is gaining popularity in this region. Along with this, the increasing popularity of cosmetic surgery, growing preference for non-operative medical solutions, advanced healthcare infrastructure and increasing medical tourism led to North America holding a market share of 38% in 2018. 

Platelets-Rich Plasma Market Growth Drivers:

· Increasing health awareness, high levels of efficacy in treating various chronic injuries, and increasing demand for cosmetic and hair loss treatment are leading to growth for the platelet-rich plasma market.

· Non-invasive PRP injection therapy reduces osteoarthritic pain, and induces tissue healing properties, thereby fueling demand for the PRP market.

· PRP is emerging as an elite alternative to more conventional forms of wound healing for tissue engineering and cellular therapy, after having shown promising results during tests by medical organizations. 

Platelets-Rich Plasma Market Challenges:

One of the major drawbacks affecting the platelets-rich plasma market is the high-cost treatment procedure, resultant tissue and nerve damage, and infection in the treated area. Despite these minor challenges, popularity of PRP therapy is peaking owing to technological innovations by healthcare agencies and the leading market companies.

Platelets-Rich Plasma Market Key Players:

The leading players of the PRP market include Zimmer Biomet, Exactech, Inc., Terumo BCT, T-Biotechnology (T-LAB), esca Therapeutics, Inc., ISTO Biologics, DePuy Synthes, Inc., Glofinn Oy, Arthrex, Inc., EmCyte Corporation, and others.

ISTO Biologics is an orthobiologic technology company which provides new innovations and efficient services to medical professionals. Their Magellan Autologous Platelet Separator system enables quick generation of PRP which can be used for several biomedical and clinical testing procedures.

Platelets-Rich Plasma Market Trends:

· PRP For Facial Rejuvenation:

Increasingly adverse effects of botox and fillers in modern facial cosmetic treatments have increased demand for PRP therapy. The minimally invasive micro needling PRP treatment effectively improves the natural collagen build up, rejuvenates the skin, and removes facial scars through quicker healing of soft tissues, and is thereby emerging as an alternative to conventional facial therapies.

· Application in Hair Loss Therapy:

Baldness and hair fall is one of the most common problems faced by people globally. PRP, which involves hair loss treatment using one’s own plasma, has emerged as an innovative new solution for hereditary hair loss problems.

Platelets-Rich Plasma Market Research Scope:

The base year of the study is 2018, with forecast done up to 2025. The study presents a thorough analysis of the competitive landscape, taking into account the market shares of the leading companies. It also provides information on unit shipments. These provide the key market participants with the necessary business intelligence and help them understand the future of the platelets-rich plasma market. The assessment includes the forecast, an overview of the competitive structure, the market shares of the competitors, as well as the market trends, market demands, market drivers, market challenges, and product analysis. The market drivers and restraints have been assessed to fathom their impact over the forecast period. This report further identifies the key opportunities for growth while also detailing the key challenges and possible threats. The key areas of focus include the types of platelets-rich plasma in platelets-rich plasma market, and their specific applications in different areas.

Platelets-Rich Plasma Market: Industry Coverage:

The segmentation of global PRP market can be done by type, source, application, and growth factor molecules. Based on the type bifurcation includes leucocyte-rich PRP, pure PRP, PRP gel, pure platelet-rich fibrin, and so on. Categorization on the basis of source includes homologous, autologous, allogeneic, and other PRP. By application the PRP market can be divided into general surgery, neurosurgery, cosmetic surgery, periodontal surgery, orthopedic/spinal surgery, and others. Classification based on growth factor molecules includes platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF), epidermal growth factor (EGF), fibroblast growth factor-2 (FGF-2), insulin-like growth factor (IGF), and others.

The platelets-rich plasma market also analyzes the major geographic regions for the market as well as the major countries for the market in these regions. The regions and countries covered in the study include:

•           North America: The U.S., Canada, Mexico

•           South America: Brazil, Venezuela, Argentina, Ecuador, Peru, Colombia, Costa Rica

•           Europe: The U.K., Germany, Italy, France, The Netherlands, Belgium, Spain, Denmark

•           APAC: China, Japan, Australia, South Korea, India, Taiwan, Malaysia, Hong Kong

•           Middle East and Africa: Israel, South Africa, Saudi Arabia


Reference:

[1] https://www.plasticsurgery.org/news/press-releases/new-statistics-reveal-the-shape-of-plastic-surgery

[2] https://www.aad.org/media/news-releases/prp-therapy-for-hair-loss

1. Platelets-Rich Plasma (PRP) Market - Overview
1.1. Definitions and Scope
2. Platelets-Rich Plasma (PRP) Market - Executive summary
2.1. Market Revenue, Market Size and Key Trends by Company
2.2. Key Trends by type of Application
2.3. Key Trends segmented by Geography
3. Platelets-Rich Plasma (PRP) Market 
3.1. Comparative analysis
3.1.1. Product Benchmarking - Top 10 companies
3.1.2. Top 5 Financials Analysis
3.1.3. Market Value split by Top 10 companies
3.1.4. Patent Analysis - Top 10 companies
3.1.5. Pricing Analysis 
4. Platelets-Rich Plasma (PRP) Market – Startup companies Scenario Premium
4.1. Top 10 startup company Analysis by
4.1.1. Investment
4.1.2. Revenue
4.1.3. Market Shares
4.1.4. Market Size and Application Analysis
4.1.5. Venture Capital and Funding Scenario
5. Platelets-Rich Plasma (PRP) Market – Industry Market Entry Scenario Premium
5.1. Regulatory Framework Overview
5.2. New Business and Ease of Doing business index
5.3. Case studies of successful ventures
5.4. Customer Analysis – Top 10 companies
6. Platelets-Rich Plasma (PRP) Market Forces
6.1. Drivers
6.2. Constraints
6.3. Challenges
6.4. Porters five force model
6.4.1. Bargaining power of suppliers
6.4.2. Bargaining powers of customers
6.4.3. Threat of new entrants
6.4.4. Rivalry among existing players
6.4.5. Threat of substitutes 
7. Platelets-Rich Plasma (PRP) Market -Strategic analysis
7.1. Value chain analysis
7.2. Opportunities analysis
7.3. Product life cycle
7.4. Suppliers and distributors Market Share
8. Platelets-Rich Plasma (PRP) Market – BY TYPE (Market Size -$Million / $Billion)
8.1. Market Size and Market Share Analysis 
8.2. Application Revenue and Trend Research
8.3. Product Segment Analysis
8.3.1. Leukocyte-Rich PRP
8.3.2. Pure PRP
8.3.3. PRP Gel
8.3.4. Pure Platelet-Rich Fibrin
8.3.5. Others
9. Platelets-Rich Plasma (PRP) Market – BY SOURCE (Market Size -$Million / $Billion)
9.1. Homologus PRP
9.2. Autologus PRP
9.3. Allogenic PRP
9.4. Others
10. Platelets-Rich Plasma (PRP) Market – BY APPLICATION (Market Size -$Million / $Billion)
10.1. General Surgery
10.2. Neurosurgery
10.3. Cosmetic Surgery
10.4. Periodontal Surgery
10.5. Orthopedic/Spinal Surgery
10.6. Cardiothoracic Surgery
10.7. Others
11. Platelets-Rich Plasma (PRP) Market – BY GROWTH FACTORMOLECULES (Market Size -$Million / $Billion)
11.1. Platelet-derived growth factor (PDGF)
11.2. Vascular endothelial growth factor (VEGF)
11.3. Epidermal growth factor (EGF)
11.4. Fibroblast growth factor-2 (FGF-2)
11.5. Insulin-like growth factor (IGF)
11.6. Others
12. Platelets-Rich Plasma (PRP) - By Geography (Market Size -$Million / $Billion)
12.1. Platelets-Rich Plasma (PRP) Market - North America Segment Research
12.2. North America Market Research (Million / $Billion)
12.2.1. Segment type Size and Market Size Analysis 
12.2.2. Revenue and Trends
12.2.3. Application Revenue and Trends by type of Application
12.2.4. Company Revenue and Product Analysis
12.2.5. North America Product type and Application Market Size
12.2.5.1. U.S.
12.2.5.2. Canada 
12.2.5.3. Mexico 
12.2.5.4. Rest of North America
12.3. Platelets-Rich Plasma (PRP) - South America Segment Research
12.4. South America Market Research (Market Size -$Million / $Billion)
12.4.1. Segment type Size and Market Size Analysis 
12.4.2. Revenue and Trends
12.4.3. Application Revenue and Trends by type of Application
12.4.4. Company Revenue and Product Analysis
12.4.5. South America Product type and Application Market Size
12.4.5.1. Brazil  
12.4.5.2. Venezuela
12.4.5.3. Argentina
12.4.5.4. Ecuador
12.4.5.5. Peru
12.4.5.6. Colombia 
12.4.5.7. Costa Rica
12.4.5.8. Rest of South America
12.5. Platelets-Rich Plasma (PRP) - Europe Segment Research
12.6. Europe Market Research (Market Size -$Million / $Billion)
12.6.1. Segment type Size and Market Size Analysis 
12.6.2. Revenue and Trends
12.6.3. Application Revenue and Trends by type of Application
12.6.4. Company Revenue and Product Analysis
12.6.5. Europe Segment Product type and Application Market Size
12.6.5.1. U.K  
12.6.5.2. Germany 
12.6.5.3. Italy 
12.6.5.4. France
12.6.5.5. Netherlands
12.6.5.6. Belgium
12.6.5.7. Spain
12.6.5.8. Denmark
12.6.5.9. Rest of Europe
12.7. Platelets-Rich Plasma (PRP) – APAC Segment Research
12.8. APAC Market Research (Market Size -$Million / $Billion)
12.8.1. Segment type Size and Market Size Analysis 
12.8.2. Revenue and Trends
12.8.3. Application Revenue and Trends by type of Application
12.8.4. Company Revenue and Product Analysis
12.8.5. APAC Segment – Product type and Application Market Size
12.8.5.1. China 
12.8.5.2. Australia
12.8.5.3. Japan 
12.8.5.4. South Korea
12.8.5.5. India
12.8.5.6. Taiwan
12.8.5.7. Malaysia
13. Platelets-Rich Plasma (PRP) Market - Entropy
13.1. New product launches
13.2. M&A's, collaborations, JVs and partnerships
14. Platelets-Rich Plasma (PRP) Market – Industry / Segment Competition landscape Premium
14.1. Market Share Analysis
14.1.1. Market Share by Country- Top companies
14.1.2. Market Share by Region- Top 10 companies
14.1.3. Market Share by type of Application – Top 10 companies
14.1.4. Market Share by type of Product / Product category- Top 10 companies
14.1.5. Market Share at global level- Top 10 companies
14.1.6. Best Practises for companies
15. Platelets-Rich Plasma (PRP) Market – Key Company List by Country Premium
16. Platelets-Rich Plasma (PRP) Market Company Analysis
16.1. Market Share, Company Revenue, Products, M&A, Developments
16.2. Arthrex, Inc.
16.3. AdiStem Ltd.
16.4. Arteriocyte Medical Systems, Inc.
16.5. Biomet, Inc.
16.6. Cesca Therapeutics, Inc
16.7. DePuy Synthes, Inc. 
16.8. EmCyte Corporation
16.9. Dr. PRP America LLC
16.10. Exactech, Inc.
16.11. Harvest Technologies Corp
16.12. Company 11
16.13. Company 12
16.14. Company 13 and more
"*Financials would be provided on a best efforts basis for private companies"
17. Platelets-Rich Plasma (PRP) Market - Appendix
17.1. Abbreviations
17.2. Sources
18. Platelets-Rich Plasma (PRP) Market - Methodology
18.1. Research Methodology
18.1.1. Company Expert Interviews
18.1.2. Industry Databases
18.1.3. Associations
18.1.4. Company News
18.1.5. Company Annual Reports
18.1.6. Application Trends
18.1.7. New Products and Product database
18.1.8. Company Transcripts
18.1.9. R&D Trends
18.1.10. Key Opinion Leaders Interviews
18.1.11. Supply and Demand Trends
List of Tables

Table 1: Platelets-Rich Plasma (PRP) Market Overview 2019-2024
Table 2: Platelets-Rich Plasma (PRP) Market Leader Analysis 2018-2019 (US$)
Table 3: Platelets-Rich Plasma (PRP) Market Product Analysis 2018-2019 (US$)
Table 4: Platelets-Rich Plasma (PRP) Market End User Analysis 2018-2019 (US$)
Table 5: Platelets-Rich Plasma (PRP) Market Patent Analysis 2013-2018* (US$)
Table 6: Platelets-Rich Plasma (PRP) Market Financial Analysis 2018-2019 (US$)
Table 7: Platelets-Rich Plasma (PRP) Market Driver Analysis 2018-2019 (US$)
Table 8: Platelets-Rich Plasma (PRP) Market Challenges Analysis 2018-2019 (US$)
Table 9: Platelets-Rich Plasma (PRP) Market Constraint Analysis 2018-2019 (US$)
Table 10: Platelets-Rich Plasma (PRP) Market Supplier Bargaining Power Analysis 2018-2019 (US$)
Table 11: Platelets-Rich Plasma (PRP) Market Buyer Bargaining Power Analysis 2018-2019 (US$)
Table 12: Platelets-Rich Plasma (PRP) Market Threat of Substitutes Analysis 2018-2019 (US$)
Table 13: Platelets-Rich Plasma (PRP) Market Threat of New Entrants Analysis 2018-2019 (US$)
Table 14: Platelets-Rich Plasma (PRP) Market Degree of Competition Analysis 2018-2019 (US$)
Table 15: Platelets-Rich Plasma (PRP) Market Value Chain Analysis 2018-2019 (US$)
Table 16: Platelets-Rich Plasma (PRP) Market Pricing Analysis 2019-2024 (US$)
Table 17: Platelets-Rich Plasma (PRP) Market Opportunities Analysis 2019-2024 (US$)
Table 18: Platelets-Rich Plasma (PRP) Market Product Life Cycle Analysis 2019-2024 (US$)
Table 19: Platelets-Rich Plasma (PRP) Market Supplier Analysis 2018-2019 (US$)
Table 20: Platelets-Rich Plasma (PRP) Market Distributor Analysis 2018-2019 (US$)
Table 21: Platelets-Rich Plasma (PRP) Market Trend Analysis 2018-2019 (US$)
Table 22: Platelets-Rich Plasma (PRP) Market Size 2018 (US$)
Table 23: Platelets-Rich Plasma (PRP) Market Forecast Analysis 2019-2024 (US$)
Table 24: Platelets-Rich Plasma (PRP) Market Sales Forecast Analysis 2019-2024 (Units)
Table 25: Platelets-Rich Plasma (PRP) Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 26: Platelets-Rich Plasma (PRP) Market By Type, Revenue & Volume, By Leukocyte-Rich PRP, 2019-2024 ($)
Table 27: Platelets-Rich Plasma (PRP) Market By Type, Revenue & Volume, By Pure PRP, 2019-2024 ($)
Table 28: Platelets-Rich Plasma (PRP) Market By Type, Revenue & Volume, By PRP Gel, 2019-2024 ($)
Table 29: Platelets-Rich Plasma (PRP) Market By Type, Revenue & Volume, By Pure Platelet-Rich Fibrin, 2019-2024 ($)
Table 30: Platelets-Rich Plasma (PRP) Market, Revenue & Volume, BY SOURCE, 2019-2024 ($)
Table 31: Platelets-Rich Plasma (PRP) Market BY SOURCE, Revenue & Volume, By Homologus PRP, 2019-2024 ($)
Table 32: Platelets-Rich Plasma (PRP) Market BY SOURCE, Revenue & Volume, By Autologus PRP, 2019-2024 ($)
Table 33: Platelets-Rich Plasma (PRP) Market BY SOURCE, Revenue & Volume, By Allogenic PRP, 2019-2024 ($)
Table 34: Platelets-Rich Plasma (PRP) Market, Revenue & Volume, By Application, 2019-2024 ($)
Table 35: Platelets-Rich Plasma (PRP) Market By Application, Revenue & Volume, By General Surgery, 2019-2024 ($)
Table 36: Platelets-Rich Plasma (PRP) Market By Application, Revenue & Volume, By Neurosurgery, 2019-2024 ($)
Table 37: Platelets-Rich Plasma (PRP) Market By Application, Revenue & Volume, By Cosmetic Surgery, 2019-2024 ($)
Table 38: Platelets-Rich Plasma (PRP) Market By Application, Revenue & Volume, By Periodontal Surgery, 2019-2024 ($)
Table 39: Platelets-Rich Plasma (PRP) Market By Application, Revenue & Volume, By Orthopedic/Spinal Surgery, 2019-2024 ($)
Table 40: North America Platelets-Rich Plasma (PRP) Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 41: North America Platelets-Rich Plasma (PRP) Market, Revenue & Volume, BY SOURCE, 2019-2024 ($)
Table 42: North America Platelets-Rich Plasma (PRP) Market, Revenue & Volume, By Application, 2019-2024 ($)
Table 43: South america Platelets-Rich Plasma (PRP) Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 44: South america Platelets-Rich Plasma (PRP) Market, Revenue & Volume, BY SOURCE, 2019-2024 ($)
Table 45: South america Platelets-Rich Plasma (PRP) Market, Revenue & Volume, By Application, 2019-2024 ($)
Table 46: Europe Platelets-Rich Plasma (PRP) Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 47: Europe Platelets-Rich Plasma (PRP) Market, Revenue & Volume, BY SOURCE, 2019-2024 ($)
Table 48: Europe Platelets-Rich Plasma (PRP) Market, Revenue & Volume, By Application, 2019-2024 ($)
Table 49: APAC Platelets-Rich Plasma (PRP) Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 50: APAC Platelets-Rich Plasma (PRP) Market, Revenue & Volume, BY SOURCE, 2019-2024 ($)
Table 51: APAC Platelets-Rich Plasma (PRP) Market, Revenue & Volume, By Application, 2019-2024 ($)
Table 52: Middle East & Africa Platelets-Rich Plasma (PRP) Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 53: Middle East & Africa Platelets-Rich Plasma (PRP) Market, Revenue & Volume, BY SOURCE, 2019-2024 ($)
Table 54: Middle East & Africa Platelets-Rich Plasma (PRP) Market, Revenue & Volume, By Application, 2019-2024 ($)
Table 55: Russia Platelets-Rich Plasma (PRP) Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 56: Russia Platelets-Rich Plasma (PRP) Market, Revenue & Volume, BY SOURCE, 2019-2024 ($)
Table 57: Russia Platelets-Rich Plasma (PRP) Market, Revenue & Volume, By Application, 2019-2024 ($)
Table 58: Israel Platelets-Rich Plasma (PRP) Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 59: Israel Platelets-Rich Plasma (PRP) Market, Revenue & Volume, BY SOURCE, 2019-2024 ($)
Table 60: Israel Platelets-Rich Plasma (PRP) Market, Revenue & Volume, By Application, 2019-2024 ($)
Table 61: Top Companies 2018 (US$)Platelets-Rich Plasma (PRP) Market, Revenue & Volume
Table 62: Product Launch 2018-2019Platelets-Rich Plasma (PRP) Market, Revenue & Volume
Table 63: Mergers & Acquistions 2018-2019Platelets-Rich Plasma (PRP) Market, Revenue & Volume


List of Figures

Figure 1: Overview of Platelets-Rich Plasma (PRP) Market 2019-2024
Figure 2: Market Share Analysis for Platelets-Rich Plasma (PRP) Market 2018 (US$)
Figure 3: Product Comparison in Platelets-Rich Plasma (PRP) Market 2018-2019 (US$)
Figure 4: End User Profile for Platelets-Rich Plasma (PRP) Market 2018-2019 (US$)
Figure 5: Patent Application and Grant in Platelets-Rich Plasma (PRP) Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in Platelets-Rich Plasma (PRP) Market 2018-2019 (US$)
Figure 7: Market Entry Strategy in Platelets-Rich Plasma (PRP) Market 2018-2019
Figure 8: Ecosystem Analysis in Platelets-Rich Plasma (PRP) Market 2018
Figure 9: Average Selling Price in Platelets-Rich Plasma (PRP) Market 2019-2024
Figure 10: Top Opportunites in Platelets-Rich Plasma (PRP) Market 2018-2019
Figure 11: Market Life Cycle Analysis in Platelets-Rich Plasma (PRP) Market
Figure 12: GlobalBy TypePlatelets-Rich Plasma (PRP) Market Revenue, 2019-2024 ($)
Figure 13: GlobalBY SOURCEPlatelets-Rich Plasma (PRP) Market Revenue, 2019-2024 ($)
Figure 14: GlobalBy ApplicationPlatelets-Rich Plasma (PRP) Market Revenue, 2019-2024 ($)
Figure 15: Global Platelets-Rich Plasma (PRP) Market - By Geography
Figure 16: Global Platelets-Rich Plasma (PRP) Market Value & Volume, By Geography, 2019-2024 ($) 
Figure 17: Global Platelets-Rich Plasma (PRP) Market CAGR, By Geography, 2019-2024 (%)
Figure 18: North America Platelets-Rich Plasma (PRP) Market Value & Volume, 2019-2024 ($)
Figure 19: US Platelets-Rich Plasma (PRP) Market Value & Volume, 2019-2024 ($)
Figure 20: US GDP and Population, 2018-2019 ($)
Figure 21: US GDP – Composition of 2018, By Sector of Origin
Figure 22: US Export and Import Value & Volume, 2018-2019 ($)
Figure 23: Canada Platelets-Rich Plasma (PRP) Market Value & Volume, 2019-2024 ($)
Figure 24: Canada GDP and Population, 2018-2019 ($)
Figure 25: Canada GDP – Composition of 2018, By Sector of Origin
Figure 26: Canada Export and Import Value & Volume, 2018-2019 ($)
Figure 27: Mexico Platelets-Rich Plasma (PRP) Market Value & Volume, 2019-2024 ($)
Figure 28: Mexico GDP and Population, 2018-2019 ($)
Figure 29: Mexico GDP – Composition of 2018, By Sector of Origin
Figure 30: Mexico Export and Import Value & Volume, 2018-2019 ($)
Figure 31: South America Platelets-Rich Plasma (PRP) Market Value & Volume, 2019-2024 ($)
Figure 32: Brazil Platelets-Rich Plasma (PRP) Market Value & Volume, 2019-2024 ($)
Figure 33: Brazil GDP and Population, 2018-2019 ($)
Figure 34: Brazil GDP – Composition of 2018, By Sector of Origin
Figure 35: Brazil Export and Import Value & Volume, 2018-2019 ($)
Figure 36: Venezuela Platelets-Rich Plasma (PRP) Market Value & Volume, 2019-2024 ($)
Figure 37: Venezuela GDP and Population, 2018-2019 ($)
Figure 38: Venezuela GDP – Composition of 2018, By Sector of Origin
Figure 39: Venezuela Export and Import Value & Volume, 2018-2019 ($)
Figure 40: Argentina Platelets-Rich Plasma (PRP) Market Value & Volume, 2019-2024 ($)
Figure 41: Argentina GDP and Population, 2018-2019 ($)
Figure 42: Argentina GDP – Composition of 2018, By Sector of Origin
Figure 43: Argentina Export and Import Value & Volume, 2018-2019 ($)
Figure 44: Ecuador Platelets-Rich Plasma (PRP) Market Value & Volume, 2019-2024 ($)
Figure 45: Ecuador GDP and Population, 2018-2019 ($)
Figure 46: Ecuador GDP – Composition of 2018, By Sector of Origin
Figure 47: Ecuador Export and Import Value & Volume, 2018-2019 ($)
Figure 48: Peru Platelets-Rich Plasma (PRP) Market Value & Volume, 2019-2024 ($)
Figure 49: Peru GDP and Population, 2018-2019 ($)
Figure 50: Peru GDP – Composition of 2018, By Sector of Origin
Figure 51: Peru Export and Import Value & Volume, 2018-2019 ($)
Figure 52: Colombia Platelets-Rich Plasma (PRP) Market Value & Volume, 2019-2024 ($)
Figure 53: Colombia GDP and Population, 2018-2019 ($)
Figure 54: Colombia GDP – Composition of 2018, By Sector of Origin
Figure 55: Colombia Export and Import Value & Volume, 2018-2019 ($)
Figure 56: Costa Rica Platelets-Rich Plasma (PRP) Market Value & Volume, 2019-2024 ($)
Figure 57: Costa Rica GDP and Population, 2018-2019 ($)
Figure 58: Costa Rica GDP – Composition of 2018, By Sector of Origin
Figure 59: Costa Rica Export and Import Value & Volume, 2018-2019 ($)
Figure 60: Europe Platelets-Rich Plasma (PRP) Market Value & Volume, 2019-2024 ($)
Figure 61: U.K Platelets-Rich Plasma (PRP) Market Value & Volume, 2019-2024 ($)
Figure 62: U.K GDP and Population, 2018-2019 ($)
Figure 63: U.K GDP – Composition of 2018, By Sector of Origin
Figure 64: U.K Export and Import Value & Volume, 2018-2019 ($)
Figure 65: Germany Platelets-Rich Plasma (PRP) Market Value & Volume, 2019-2024 ($)
Figure 66: Germany GDP and Population, 2018-2019 ($)
Figure 67: Germany GDP – Composition of 2018, By Sector of Origin
Figure 68: Germany Export and Import Value & Volume, 2018-2019 ($)
Figure 69: Italy Platelets-Rich Plasma (PRP) Market Value & Volume, 2019-2024 ($)
Figure 70: Italy GDP and Population, 2018-2019 ($)
Figure 71: Italy GDP – Composition of 2018, By Sector of Origin
Figure 72: Italy Export and Import Value & Volume, 2018-2019 ($)
Figure 73: France Platelets-Rich Plasma (PRP) Market Value & Volume, 2019-2024 ($)
Figure 74: France GDP and Population, 2018-2019 ($)
Figure 75: France GDP – Composition of 2018, By Sector of Origin
Figure 76: France Export and Import Value & Volume, 2018-2019 ($)
Figure 77: Netherlands Platelets-Rich Plasma (PRP) Market Value & Volume, 2019-2024 ($)
Figure 78: Netherlands GDP and Population, 2018-2019 ($)
Figure 79: Netherlands GDP – Composition of 2018, By Sector of Origin
Figure 80: Netherlands Export and Import Value & Volume, 2018-2019 ($)
Figure 81: Belgium Platelets-Rich Plasma (PRP) Market Value & Volume, 2019-2024 ($)
Figure 82: Belgium GDP and Population, 2018-2019 ($)
Figure 83: Belgium GDP – Composition of 2018, By Sector of Origin
Figure 84: Belgium Export and Import Value & Volume, 2018-2019 ($)
Figure 85: Spain Platelets-Rich Plasma (PRP) Market Value & Volume, 2019-2024 ($)
Figure 86: Spain GDP and Population, 2018-2019 ($)
Figure 87: Spain GDP – Composition of 2018, By Sector of Origin
Figure 88: Spain Export and Import Value & Volume, 2018-2019 ($)
Figure 89: Denmark Platelets-Rich Plasma (PRP) Market Value & Volume, 2019-2024 ($)
Figure 90: Denmark GDP and Population, 2018-2019 ($)
Figure 91: Denmark GDP – Composition of 2018, By Sector of Origin
Figure 92: Denmark Export and Import Value & Volume, 2018-2019 ($)
Figure 93: APAC Platelets-Rich Plasma (PRP) Market Value & Volume, 2019-2024 ($)
Figure 94: China Platelets-Rich Plasma (PRP) Market Value & Volume, 2019-2024
Figure 95: China GDP and Population, 2018-2019 ($)
Figure 96: China GDP – Composition of 2018, By Sector of Origin
Figure 97: China Export and Import Value & Volume, 2018-2019 ($)Platelets-Rich Plasma (PRP) Market China Export and Import Value & Volume, 2018-2019 ($)
Figure 98: Australia Platelets-Rich Plasma (PRP) Market Value & Volume, 2019-2024 ($)
Figure 99: Australia GDP and Population, 2018-2019 ($)
Figure 100: Australia GDP – Composition of 2018, By Sector of Origin
Figure 101: Australia Export and Import Value & Volume, 2018-2019 ($)
Figure 102: South Korea Platelets-Rich Plasma (PRP) Market Value & Volume, 2019-2024 ($)
Figure 103: South Korea GDP and Population, 2018-2019 ($)
Figure 104: South Korea GDP – Composition of 2018, By Sector of Origin
Figure 105: South Korea Export and Import Value & Volume, 2018-2019 ($)
Figure 106: India Platelets-Rich Plasma (PRP) Market Value & Volume, 2019-2024 ($)
Figure 107: India GDP and Population, 2018-2019 ($)
Figure 108: India GDP – Composition of 2018, By Sector of Origin
Figure 109: India Export and Import Value & Volume, 2018-2019 ($)
Figure 110: Taiwan Platelets-Rich Plasma (PRP) Market Value & Volume, 2019-2024 ($)
Figure 111: Taiwan GDP and Population, 2018-2019 ($)
Figure 112: Taiwan GDP – Composition of 2018, By Sector of Origin
Figure 113: Taiwan Export and Import Value & Volume, 2018-2019 ($)
Figure 114: Malaysia Platelets-Rich Plasma (PRP) Market Value & Volume, 2019-2024 ($)
Figure 115: Malaysia GDP and Population, 2018-2019 ($)
Figure 116: Malaysia GDP – Composition of 2018, By Sector of Origin
Figure 117: Malaysia Export and Import Value & Volume, 2018-2019 ($)
Figure 118: Hong Kong Platelets-Rich Plasma (PRP) Market Value & Volume, 2019-2024 ($)
Figure 119: Hong Kong GDP and Population, 2018-2019 ($)
Figure 120: Hong Kong GDP – Composition of 2018, By Sector of Origin
Figure 121: Hong Kong Export and Import Value & Volume, 2018-2019 ($)
Figure 122: Middle East & Africa Platelets-Rich Plasma (PRP) Market Middle East & Africa 3D Printing Market Value & Volume, 2019-2024 ($)
Figure 123: Russia Platelets-Rich Plasma (PRP) Market Value & Volume, 2019-2024 ($)
Figure 124: Russia GDP and Population, 2018-2019 ($)
Figure 125: Russia GDP – Composition of 2018, By Sector of Origin
Figure 126: Russia Export and Import Value & Volume, 2018-2019 ($)
Figure 127: Israel Platelets-Rich Plasma (PRP) Market Value & Volume, 2019-2024 ($)
Figure 128: Israel GDP and Population, 2018-2019 ($)
Figure 129: Israel GDP – Composition of 2018, By Sector of Origin
Figure 130: Israel Export and Import Value & Volume, 2018-2019 ($)
Figure 131: Entropy Share, By Strategies, 2018-2019* (%)Platelets-Rich Plasma (PRP) Market
Figure 132: Developments, 2018-2019*Platelets-Rich Plasma (PRP) Market
Figure 133: Company 1 Platelets-Rich Plasma (PRP) Market Net Revenue, By Years, 2018-2019* ($)
Figure 134: Company 1 Platelets-Rich Plasma (PRP) Market Net Revenue Share, By Business segments, 2018 (%)
Figure 135: Company 1 Platelets-Rich Plasma (PRP) Market Net Sales Share, By Geography, 2018 (%)
Figure 136: Company 2 Platelets-Rich Plasma (PRP) Market Net Revenue, By Years, 2018-2019* ($)
Figure 137: Company 2 Platelets-Rich Plasma (PRP) Market Net Revenue Share, By Business segments, 2018 (%)
Figure 138: Company 2 Platelets-Rich Plasma (PRP) Market Net Sales Share, By Geography, 2018 (%)
Figure 139: Company 3 Platelets-Rich Plasma (PRP) Market Net Revenue, By Years, 2018-2019* ($)
Figure 140: Company 3 Platelets-Rich Plasma (PRP) Market Net Revenue Share, By Business segments, 2018 (%)
Figure 141: Company 3 Platelets-Rich Plasma (PRP) Market Net Sales Share, By Geography, 2018 (%)
Figure 142: Company 4 Platelets-Rich Plasma (PRP) Market Net Revenue, By Years, 2018-2019* ($)
Figure 143: Company 4 Platelets-Rich Plasma (PRP) Market Net Revenue Share, By Business segments, 2018 (%)
Figure 144: Company 4 Platelets-Rich Plasma (PRP) Market Net Sales Share, By Geography, 2018 (%)
Figure 145: Company 5 Platelets-Rich Plasma (PRP) Market Net Revenue, By Years, 2018-2019* ($)
Figure 146: Company 5 Platelets-Rich Plasma (PRP) Market Net Revenue Share, By Business segments, 2018 (%)
Figure 147: Company 5 Platelets-Rich Plasma (PRP) Market Net Sales Share, By Geography, 2018 (%)
Figure 148: Company 6 Platelets-Rich Plasma (PRP) Market Net Revenue, By Years, 2018-2019* ($)
Figure 149: Company 6 Platelets-Rich Plasma (PRP) Market Net Revenue Share, By Business segments, 2018 (%)
Figure 150: Company 6 Platelets-Rich Plasma (PRP) Market Net Sales Share, By Geography, 2018 (%)
Figure 151: Company 7 Platelets-Rich Plasma (PRP) Market Net Revenue, By Years, 2018-2019* ($)
Figure 152: Company 7 Platelets-Rich Plasma (PRP) Market Net Revenue Share, By Business segments, 2018 (%)
Figure 153: Company 7 Platelets-Rich Plasma (PRP) Market Net Sales Share, By Geography, 2018 (%)
Figure 154: Company 8 Platelets-Rich Plasma (PRP) Market Net Revenue, By Years, 2018-2019* ($)
Figure 155: Company 8 Platelets-Rich Plasma (PRP) Market Net Revenue Share, By Business segments, 2018 (%)
Figure 156: Company 8 Platelets-Rich Plasma (PRP) Market Net Sales Share, By Geography, 2018 (%)
Figure 157: Company 9 Platelets-Rich Plasma (PRP) Market Net Revenue, By Years, 2018-2019* ($)
Figure 158: Company 9 Platelets-Rich Plasma (PRP) Market Net Revenue Share, By Business segments, 2018 (%)
Figure 159: Company 9 Platelets-Rich Plasma (PRP) Market Net Sales Share, By Geography, 2018 (%)
Figure 160: Company 10 Platelets-Rich Plasma (PRP) Market Net Revenue, By Years, 2018-2019* ($)
Figure 161: Company 10 Platelets-Rich Plasma (PRP) Market Net Revenue Share, By Business segments, 2018 (%)
Figure 162: Company 10 Platelets-Rich Plasma (PRP) Market Net Sales Share, By Geography, 2018 (%)
Figure 163: Company 11 Platelets-Rich Plasma (PRP) Market Net Revenue, By Years, 2018-2019* ($)
Figure 164: Company 11 Platelets-Rich Plasma (PRP) Market Net Revenue Share, By Business segments, 2018 (%)
Figure 165: Company 11 Platelets-Rich Plasma (PRP) Market Net Sales Share, By Geography, 2018 (%)
Figure 166: Company 12 Platelets-Rich Plasma (PRP) Market Net Revenue, By Years, 2018-2019* ($)
Figure 167: Company 12 Platelets-Rich Plasma (PRP) Market Net Revenue Share, By Business segments, 2018 (%)
Figure 168: Company 12 Platelets-Rich Plasma (PRP) Market Net Sales Share, By Geography, 2018 (%)
Figure 169: Company 13 Platelets-Rich Plasma (PRP) Market Net Revenue, By Years, 2018-2019* ($)
Figure 170: Company 13 Platelets-Rich Plasma (PRP) Market Net Revenue Share, By Business segments, 2018 (%)
Figure 171: Company 13 Platelets-Rich Plasma (PRP) Market Net Sales Share, By Geography, 2018 (%)
Figure 172: Company 14 Platelets-Rich Plasma (PRP) Market Net Revenue, By Years, 2018-2019* ($)
Figure 173: Company 14 Platelets-Rich Plasma (PRP) Market Net Revenue Share, By Business segments, 2018 (%)
Figure 174: Company 14 Platelets-Rich Plasma (PRP) Market Net Sales Share, By Geography, 2018 (%)
Figure 175: Company 15 Platelets-Rich Plasma (PRP) Market Net Revenue, By Years, 2018-2019* ($)
Figure 176: Company 15 Platelets-Rich Plasma (PRP) Market Net Revenue Share, By Business segments, 2018 (%)
Figure 177: Company 15 Platelets-Rich Plasma (PRP) Market Net Sales Share, By Geography, 2018 (%)